Last updated on November 2017

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis


Brief description of study

A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis

Detailed Study Description

The purpose of the study is to evaluate the effect of Velusetrag on: symptoms in subjects with gastroparesis, gastric emptying, and nausea improvement.

Clinical Study Identifier: TX5552

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

MariCarmen Korngiebel-Rosique, MS, CRC

Gastroenterology Associates of Tidewater
Chesapeake, VA USA
  Connect »